Skip to content

Frequently Asked Questions

FAQs

References

  1. Hawkins, J., Idoine, R., Kwon, J., Shao, A., Dunne, E., Hawkins, E., Dawson, K., & Nkrumah-Elie, Y. (2024). Randomized, placebo-controlled, pilot clinical study evaluating acute Niagen®+ IV and NAD+ IV in healthy adults. MedRxiv, 2024.06.06.24308565. https://doi.org/10.1101/2024.06.06.24308565
  2. Trammell, S. A. J., Schmidt, M. S., Weidemann, B. J., Redpath, P., Jaksch, F., Dellinger, R. W., Li, Z., Abel, E. D., Migaud, M. E., & Brenner, C. (2016). Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nature Communications, 7(1), 12948. https://doi.org/10.1038/ncomms12948
  3. Berven, H., Kverneng, S., Sheard, E., Søgnen, M., Geijerstam, S. A. A., Haugarvoll, K., Skeie, G.-O., Dölle, C., & Tzoulis, C. (2023). NR-SAFE: a randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson’s disease. Nature Communications, 14(1), 7793. https://doi.org/10.1038/s41467-023-43514-6
  4. Gaare, J. J., Dölle, C., Brakedal, B., Brügger, K., Haugarvoll, K., Nido, G. S., & Tzoulis, C. (2023). Nicotinamide riboside supplementation is not associated with altered methylation homeostasis in Parkinson’s disease. IScience, 26(3), 106278. https://doi.org/10.1016/j.isci.2023.106278
  5. Bhandari, R., Lukas, K., Lee, K., Shamunee, J., Almeida, B., Guzman, T., Echevarria, M., Lindenfeld, L., Nenninger, C., Iukuridze, A., Albanese, S., Rhee, J., Chen, S., Brenner, C., Wong, F. L., & Armenian, S. H. (2025). Feasibility of telehealth exercise and nicotinamide riboside supplementation in survivors of childhood cancer at risk for diabetes: A pilot randomized controlled trial. Pediatric Blood & Cancer, 72(1), e31369. https://doi.org/10.1002/pbc.31369
  6. Conze, D., Brenner, C., & Kruger, C. L. (2019). Safety and Metabolism of Long-term Administration of NIAGEN (Nicotinamide Riboside Chloride) in a Randomized, Double-Blind, Placebo-controlled Clinical Trial of Healthy Overweight Adults. Scientific Reports, 9(1), 9772. https://doi.org/10.1038/s41598-019-46120-z